MotoyamaTOkamotoKKukitaIHamaguchiMKinoshitaYOgawaH.Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome. Crit Care Med. 2003;31: 1048-1052.
2.
BorrelliERoux-LombardPGrauGE. Plasma concentration of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med. 1996;24:392-397.
3.
ForcevilleXVitouxDGauzitRCombesALahilairePChappuisP.Selenium, systemic immune response syndrome, sepsis and outcome in critically ill patients. Crit Care Med. 1998;26:1536-1544.
4.
Oudemans-van StraatenHMBosmanRJTreskesMvan der SpoelHJZandstraDF.Plasma glutamine depletion and patient outcome in acute ICU admissions. Intensive Care Med. 2001;27(1):84-90.
5.
RaymanMP.The importance of selenium to human health. Lancet. 2000;356:233-241.
6.
WischmeyerPE.Glutamine: mode of action in critical illness. Crit Care Med. 2007;35:S541-S544.
7.
NovakFHeylandDKAvenellANovakFDroverJSuX.Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med. 2002;30:2022-2029.
8.
ManzanaresWDhaliwalRJiangXMurchLHeylandDK.Antioxidants micronutrients in the critically ill: a systematic review and meta-analysis. Crit Care. 2012;16(2):R66.
9.
HeylandDMuscedereJWischmeyerPE. A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med. 2013:368(16):1487-1495.
10.
RodasPCRooyackersOHebertCNorbergAWernermanJ.Glutamine and glutathione at ICU admission in relation to outcome. Clin Sci (Lond). 2012;122:591-597.
